LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 14 filers reported holding LAVA THERAPEUTICS NV in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -27.6% | 200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $406 | +22.3% | 200,000 | 0.0% | 0.01% | -35.0% |
| Q1 2023 | $332 | -52.6% | 200,000 | 0.0% | 0.02% | -48.7% |
| Q4 2022 | $700 | -99.9% | 200,000 | 0.0% | 0.04% | 0.0% |
| Q3 2022 | $914,000 | +54.9% | 200,000 | 0.0% | 0.04% | +21.9% |
| Q2 2022 | $590,000 | -33.0% | 200,000 | 0.0% | 0.03% | -13.5% |
| Q1 2022 | $880,000 | -20.0% | 200,000 | 0.0% | 0.04% | +23.3% |
| Q4 2021 | $1,100,000 | -7.1% | 200,000 | 0.0% | 0.03% | +15.4% |
| Q3 2021 | $1,184,000 | -45.6% | 200,000 | 0.0% | 0.03% | -40.9% |
| Q2 2021 | $2,176,000 | -28.4% | 200,000 | 0.0% | 0.04% | -18.5% |
| Q1 2021 | $3,038,000 | – | 200,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |